Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of (R) and (S) Propafenone for AF Prevention
NCT02710669Phase 2Terminated
- Sponsor
- Vanderbilt University
- Start
- Oct 2016
- Primary completion
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of (R)-propafenone in Atrial fibrillation (AFib), sponsored by Vanderbilt University. Started Oct 2016; status: terminated.
02
Drugs
(R)-propafenone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT02710669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02710669.